OMX Nordic 40
2.436,11
PKT
+0,53
PKT
+0,02
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.11.12 | Ericsson (Telefon L.M.Ericsson) (B) outperform | Cheuvreux SA | |
| 05.11.12 | Nokia neutral | J.P. Morgan Cazenove | |
| 05.11.12 | Nokia neutral | Exane-BNP Paribas SA | |
| 05.11.12 | Nokia sell | Société Générale Group S.A. (SG) | |
| 05.11.12 | Sandvik neutral | Nomura | |
| 02.11.12 | Carlsberg outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Carlsberg sell | Société Générale Group S.A. (SG) | |
| 01.11.12 | Danske Bank buy | Deutsche Bank AG | |
| 01.11.12 | Danske Bank hold | Société Générale Group S.A. (SG) | |
| 01.11.12 | Novo Nordisk sell | Société Générale Group S.A. (SG) | |
| 31.10.12 | Danske Bank underperform | Exane-BNP Paribas SA | |
| 31.10.12 | Danske Bank reduce | Nomura | |
| 31.10.12 | Novo Nordisk neutral | Sarasin Research | |
| 31.10.12 | Danske Bank overweight | J.P. Morgan Cazenove | |
| 31.10.12 | Danske Bank neutral | UBS AG | |
| 31.10.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 30.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 30.10.12 | Ericsson (Telefon L.M.Ericsson) (B) kaufen | Independent Research GmbH | |
| 30.10.12 | ABB (Asea Brown Boveri) equal-weight | Morgan Stanley | |
| 30.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 30.10.12 | Ericsson (Telefon L.M.Ericsson) (B) hold | Deutsche Bank AG | |
| 30.10.12 | Nokia sell | Société Générale Group S.A. (SG) | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) underperform | Credit Suisse Group | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) outperform | Exane-BNP Paribas SA | |
| 29.10.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 29.10.12 | Hennes Mauritz (H M, H&M) underperform | Credit Suisse Group | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) neutral | UBS AG | |
| 29.10.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) hold | Société Générale Group S.A. (SG) | |
| 29.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 26.10.12 | Sandvik neutral | Exane-BNP Paribas SA | |
| 26.10.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Sandvik sell | Société Générale Group S.A. (SG) | |
| 26.10.12 | Novo Nordisk sell | Société Générale Group S.A. (SG) | |
| 26.10.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | Skandinaviska Enskilda Banken (SEB) sell | Société Générale Group S.A. (SG) | |
| 26.10.12 | Skandinaviska Enskilda Banken (SEB) buy | UBS AG | |
| 26.10.12 | Skandinaviska Enskilda Banken (SEB) neutral | Exane-BNP Paribas SA | |
| 26.10.12 | Novo Nordisk equal-weight | Morgan Stanley |